ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026
Understanding vaccination against human papillomavirus (HPV): knowledge and perceptions among parents or guardians and healthcare workers, Germany, 2023.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUNDVaccination against human papillomavirus (HPV) is effective against certain types of cancer. Despite longstanding vaccination recommendation, HPV vaccination has the lowest coverage among all recommended vaccines for children and adolescents in Germany, with notable differences between sexes.AIMWe aimed to investigate attitudes towards vaccination against HPV and HPV-related knowledge among parents or guardians and healthcare workers (HCW) in Germany, alongside vaccination intentions and determinants in parents/guardians and vaccination counselling in HCWs.METHODSIn autumn 2023, we conducted telephone interviews with 1,508 parents/guardians of children and adolescents aged 9-14 years and 503 HCWs from paediatric practices. We used weighting and analysed the responses with t test and ANOVA.RESULTSOverall, 34.5% children of the interviewed parents/guardians were already vaccinated against HPV, while 24.8% of parents/guardians reported a high intention, 5.6% opposed to vaccination and 35.2% were considered vaccine hesitant. Parents/guardians and HCWs considered vaccination of females more important than of males (p < 0.001). Parents/guardians exhibited knowledge gaps, for example, by overestimating alternative measures (e.g. condom use) for cancer prevention; HCWs expressed uncertainties about the risk of HPV infection. Vaccination decisions were most strongly influenced by the paediatricians the parents/guardians consulted. Although 97% of HCWs reported recommending the vaccine, only 43.7% of parents/guardians recalled receiving a recommendation.CONCLUSIONThese findings highlight the need for tailored vaccination communication, alongside timely, active physician recommendations and appropriate education to support HPV vaccination decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.